Y ou’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life ...

Since his first term, Trump has promised to lower U.S. drug prices to levels charged in other rich countries. On Friday, the ...

The health sector is working to navigate what could be the most significant changes to the U.S. vaccine program in decades.

Under a rule proposed by the Trump administration, pharma companies and pharmacy benefit managers will still not have to post ...

Read the conversation that Nalis had with Morgentaler to learn how testosterone originally fell out of favor in medicine, how it came back, and what a castrated lizard had to do with it all. FDA ...

Good morning, Pharmalittle readers. This is Allison DeAngelis, filling in for Mr. Pharmalot. Today’s newsletter is brought to you by the dark roast Keurig pods I brought with me on my holiday travels.

Federal agencies that used to set up guardrails for health technology have transformed into cheerleaders for new risky technologies like AI.

Something remarkable is happening in Chinese biotech, and it’s happening fast. The country’s drug developers are learning to ...

The choice that one person makes not to vaccinate has real costs — financial and otherwise — for their neighbors.

The Trump administration wants to scrap rules that require developers to disclose how AI tools used to treat patients were ...

The FDA has approved the oral version of Novo Nordisk’s injectable weight loss drug Wegovy, making it the first GLP-1 pill to ...